Guo Meng
Director/Board Member presso SSY GROUP LIMITED
Patrimonio netto: 12 M $ in data 30/04/2024
Profilo
Guo Meng is currently an Executive Director & Deputy General Manager at SSY Group Ltd., a Director at New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd., and a Director at Hebei Guolong Pharmaceutical Co., Ltd.
Previously, Mr. Meng served as the Executive President & Director at Shijiazhuang No.
4 Pharmaceutical Co., Ltd.
Mr. Meng's education includes an undergraduate degree from Lanzhou University and a graduate degree from Beijing University of Technology.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
SSY GROUP LIMITED
0.67% | 30/06/2023 | 20 000 000 ( 0.67% ) | 12 M $ | 30/04/2024 |
Posizioni attive di Guo Meng
Società | Posizione | Inizio |
---|---|---|
SSY GROUP LIMITED | Director/Board Member | 27/08/2021 |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The private company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Director/Board Member | - |
Hebei Guolong Pharmaceutical Co., Ltd. | Director/Board Member | - |
Precedenti posizioni note di Guo Meng
Società | Posizione | Fine |
---|---|---|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | President | - |
Formazione di Guo Meng
Lanzhou University | Undergraduate Degree |
Beijing University of Technology | Graduate Degree |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
SSY GROUP LIMITED | Health Technology |
Aziende private | 3 |
---|---|
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The private company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
Hebei Guolong Pharmaceutical Co., Ltd. |
- Borsa valori
- Insiders
- Guo Meng